Global Allergy Immunotherapies Market Analysis & Forecast 2019-2023: The Increasing Prevalence of Various Types of Allergies is Augmenting Growth (Over 7%) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–

The “Global
Allergy Immunotherapies Market 2019-2023”
report has been added
to ResearchAndMarkets.com’s offering.
The allergy immunotherapies market is forecast register a CAGR of more
than 7% by 2023.
The latest trend gaining momentum in the market is the emerging drug
development technologies. According to the report, one of the major
drivers for this market is the increasing prevalence of various types
of allergies. Further, the report states that one of the major factors
hindering the growth of this market is the unknown pathogenesis.

The emerging drug development technologies is likely to help the market
grow during the forecast period. The recent advances in the
immunotherapy drug development are helping the pharmaceutical companies
to develop more efficient immunotherapies for the treatment of various
allergies.

The increasing prevalence of various types of allergies across the globe
is driving the allergy immunotherapies market. The growing occurrence of
allergy is generated by the factors such as increasing pollution and
augmented consumption of tobacco products like cigarettes, which is
likely to boost the global allergy immunotherapy market.

The unknown pathogenesis of various allergies is the major challenge
faced by the global allergy immunotherapies market. The unclear cause of
allergy results in physicians misdiagnosing the allergen, and as a
result the treatment prescribed is not as effective as it should be, and
it often leads to adverse events.

With the presence of a considerable number of companies, this market
appears to be fragmented. The current advances in the immunotherapy drug
development are helping the pharmaceutical companies to develop more
effective immunotherapies for the treatment of various allergies.
Several established allergy immunotherapy manufacturers are striving for
their share of the global allergy immunotherapies market, and the new
players must differentiate themselves to gain vital traction over their
competitors.
Key Players
  • ALK
  • Allergy Therapeutics
  • HAL Allergy
  • Merck
  • Stallergenes Greer

Topics Covered

1. Executive Summary

2. Scope of the Report

3. Market Landscape

4. Market Sizing

5. Five Forces Analysis

6. Market Segmentation by Product

7. Customer Landscape

8. Geographic Landscape

9. Decision Framework

10. Drivers and Challenges

11. Market Trends

12. Vendor Landscape

13. Vendor Analysis
For more information about this report visit https://www.researchandmarkets.com/research/7wj84v/global_allergy?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Allergy
Drugs